Erythropoietin as a treatment of anemia in heart failure: Systematic review of randomized trials

American Heart Journal

Volumn 161, Issue 5, 2011, Pages

  Kotecha, Dipak ^a,b   Ngo, Katherine ^c   Walters, Julia A E ^d   Manzano, Luis ^e   Palazzuoli, Alberto ^f   Flather, Marcus D ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

^b MONASH UNIVERSITY   (Australia)

^c UNIVERSITY OF TASMANIA   (Australia)

^d UNIVERSITY OF TASMANIA   (Australia)

^e UNIVERSITY OF ALCALÁ   (Spain)

^f UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANEMIC AGENT; BRAIN NATRIURETIC PEPTIDE; CARVEDILOL; ENALAPRIL; ERYTHROPOIETIN; FOLIC ACID; IRON; METOPROLOL; NOVEL ERYTHROPOIESIS STIMULATING PROTEIN; PLACEBO; RECOMBINANT ERYTHROPOIETIN; SPIRONOLACTONE; VALSARTAN;

ANEMIA; ARTICLE; CHRONIC DISEASE; COMORBIDITY; DOUBLE BLIND PROCEDURE; ERYTHROPOIESIS; EXERCISE TOLERANCE; HEART EJECTION FRACTION; HEART FAILURE; HEMOGLOBIN BLOOD LEVEL; HOSPITALIZATION; HUMAN; META ANALYSIS; MORTALITY; OXYGEN CONSUMPTION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYMPTOMATOLOGY; SYSTEMATIC REVIEW; UNSPECIFIED SIDE EFFECT;

EID: 79955885170     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2011.02.013     Document Type: Review

References (46)

1. J.E. Mitchell Emerging role of anemia in heart failure Am J Cardiol 99 2007 S15 S20
2. H.F. Groenveld, J.L. Januzzi, and K. Damman Anemia and mortality in heart failure patients a systematic review and meta-analysis J Am Coll Cardiol 52 2008 818 827
3. E.F. Unger, A.M. Thompson, and M.J. Blank Erythropoiesis-stimulating agents-time for a reevaluation N Engl J Med 362 2010 189 192
4. A. Phrommintikul, S.J. Haas, and M. Elsik Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis Lancet 369 2007 381 388 (Pubitemid 46188479)
5. M. Kimel, N.K. Leidy, and S. Mannix Does epoetin alfa improve health-related quality of life in chronically ill patients with anemia? Summary of trials of cancer, HIV/AIDS, and chronic kidney disease Value Health 11 2008 57 75 (Pubitemid 351160877)
6. P. van der Meer, H.F. Groenveld, J.L. Januzzi Jr., and D.J. van Veldhuisen Erythropoietin treatment in patients with chronic heart failure: a meta-analysis Heart 95 2009 1309 1314
7. D. Moher, A. Liberati, and J. Tetzlaff Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement BMJ b2535 2009 339
8. J.P.T. Higgins, and S. Green Cochrane handbook for systematic reviews of interventions version 5.0.1 [updated September 2008] 2008 The Cochrane Collaboration www.cochrane-handbook.org Available from
9. N. Mantel, and W. Haenszel Statistical aspects of the analysis of data from retrospective studies of disease J Natl Cancer Inst 22 1959 719 748
10. R. DerSimonian, and N. Laird Meta-analysis in clinical trials Control Clin Trials 7 1986 177 188 (Pubitemid 17189972)
11. D.M. Mancini, S.D. Katz, and C.C. Lang Effect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failure Circulation 107 2003 294 299 (Pubitemid 36135227)
12. B. Cosyns, S. Velez-Roa, and S. Droogmans Effects of eythropoietin administration on mitral regurgitation and left ventricular remodeling in heart failure patients Int J Cardiol 138 2010 306 307
13. J.K. Ghali, I.S. Anand, and W.T. Abraham Randomized double-blind trial of darbepoetin alfa in patients with symptomatic heart failure and anemia Circulation 117 2008 526 535
14. J.G. Cleland, J.T. Sullivan, and S. Ball Once-monthly administration of darbepoetin alfa for the treatment of patients with chronic heart failure and anemia: a pharmacokinetic and pharmacodynamic investigation J Cardiovasc Pharmacol 46 2005 155 161 (Pubitemid 41060207)
15. D.J. van Veldhuisen, K. Dickstein, and A. Cohen-Solal Randomized, double-blind, placebo-controlled study to evaluate the effect of two dosing regimens of darbepoetin alfa in patients with heart failure and anaemia Eur Heart J 28 2007 2208 2216 (Pubitemid 47428946)
16. K. Kourea, J.T. Parissis, and D. Farmakis Effects of darbepoetin-alpha on quality of life and emotional stress in anemic patients with chronic heart failure Eur J Cardiovasc Prev Rehabil 15 2008 365 369
17. A. Palazzuoli, D. Silverberg, and F. Iovine Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemia Am Heart J 152 2006 1096.e9 1096.e15
18. A. Palazzuoli, D.S. Silverberg, and F. Iovine Effects of beta-erythropoietin treatment on left ventricular remodeling, systolic function, and B-type natriuretic peptide levels in patients with the cardiorenal anemia syndrome Am Heart J 154 2007 645.e9 645.e15
19. J.T. Parissis, K. Kourea, and F. Panou Effects of darbepoetin alpha on right and left ventricular systolic and diastolic function in anemic patients with chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy Am Heart J 155 2008 751.e1 751.e7
20. P. Ponikowski, S.D. Anker, and J. Szachniewicz Effect of darbepoetin alfa on exercise tolerance in anemic patients with symptomatic chronic heart failure: a randomized, double-blind, placebo-controlled trial J Am Coll Cardiol 49 2007 753 762 (Pubitemid 46240705)
21. D.S. Silverberg, D. Wexler, and D. Sheps The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study J Am Coll Cardiol 37 2001 1775 1780 (Pubitemid 32499958)
22. J. Abdulla, S.Z. Abildstrom, and E. Christensen A meta-analysis of the effect of angiotensin-converting enzyme inhibitors on functional capacity in patients with symptomatic left ventricular systolic dysfunction Eur J Heart Fail 6 2004 927 935 (Pubitemid 39536309)
23. W.T. Abraham, W.G. Fisher, and A.L. Smith Cardiac resynchronization in chronic heart failure N Engl J Med 346 2002 1845 1853 (Pubitemid 34603028)
24. J.A. Ezekowitz, and F.A. McAlister Aldosterone blockade and left ventricular dysfunction: a systematic review of randomized clinical trials Eur Heart J 30 2009 469 477
25. C.K. Morris, K. Ueshima, and T. Kawaguchi The prognostic value of exercise capacity: a review of the literature Am Heart J 122 1991 1423 1431
26. M. Klapholz, W.T. Abraham, and J.K. Ghali The safety and tolerability of darbepoetin alfa in patients with anaemia and symptomatic heart failure Eur J Heart Fail 11 2009 1071 1077
27. C.L. Bennett, S.M. Silver, and B. Djulbegovic Venous thromboembolism and mortality associated with recombinant erythropoietin and darbepoetin administration for the treatment of cancer-associated anemia JAMA 299 2008 914 924 (Pubitemid 351397066)
28. J. Bohlius, J. Wilson, and J. Seidenfeld Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 studies including 9353 patients J Natl Canc Inst 98 2006 708 714 (Pubitemid 43821788)
29. M.A. Pfeffer, E.A. Burdmann, and C.Y. Chen A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease N Engl J Med 361 2009 2019 2032
30. L.A. Szczech, H.X. Barnhart, and J.K. Inrig Secondary analysis of the CHOIR trial epoetin-alpha dose and achieved hemoglobin outcomes Kidney Int 74 2008 791 798
31. M.C. Shibata, M.D. Flather, and D. Wang Systematic review of the impact of beta blockers on mortality and hospital admissions in heart failure Eur J Heart Fail 3 2001 351 357 (Pubitemid 32895844)
32. The Digitalis Investigation Group The effect of digoxin on mortality and morbidity in patients with heart failure New Engl J Med 336 1997 525 533
33. M.D. Flather, S. Yusuf, and L. Køber Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients Lancet 355 2000 1575 1581 (Pubitemid 30240501)
34. D. Okonko, and S.D. Anker Anemia in chronic heart failure: pathogenetic mechanisms J Card Fail 10 2004 S5 S9
35. I.S. Anand Anemia and chronic heart failure implications and treatment options J Am Coll Cardiol 52 2008 501 511
36. M. Packer, G.V. Antonopoulos, and J.A. Berlin Comparative effects of carvedilol and metoprolol on left ventricular ejection fraction in heart failure: results of a meta-analysis Am Heart J 141 2001 899 907 (Pubitemid 32477000)
37. P. van der Meer, E. Lipsic, and W.H. van Gilst Anemia and erythropoietin in heart failure Heart Fail Monit 6 2008 28 33
38. M. Ferrario, E. Arbustini, and M. Massa High-dose erythropoietin in patients with acute myocardial infarction: a pilot, randomised, placebo-controlled study Int J Cardiol 2009
39. A.A. Voors, A.M. Belonje, and F. Zijlstra A single dose of erythropoietin in ST-elevation myocardial infarction Eur Heart J 31 2010 2593 2600
40. N. Terrin, C.H. Schmid, and J. Lau In an empirical evaluation of the funnel plot, researchers could not visually identify publication bias J Clin Epidemiol 58 2005 894 901 (Pubitemid 41115773)
41. K. Tangdhanakanond, and R. Raja Effect of statins on erythropoietin responsiveness in type 2-diabetic versus non-diabetic hemodialysis patients Clin Nephrol 73 2010 1 6
42. J.J. McMurray, I.S. Anand, and R. Diaz Design of the Reduction of Events with Darbepoetin alfa in Heart Failure (RED-HF): a Phase III, anaemia correction, morbidity-mortality trial Eur J Heart Fail 11 2009 795 801
43. M.E. Davis, A.M. Richards, and M.G. Nicholls Introduction of metoprolol increases plasma B-type cardiac natriuretic peptides in mild, stable heart failure Circulation 113 2006 977 985 (Pubitemid 43879473)
44. M. Feola, E. Menardi, and F. Ribichini Effects of the addition of a low dose of spironolactone on brain natriuretic peptide plasma level and cardiopulmonary function in patients with moderate congestive heart failure Med Sci Monit 9 2003 CR341 5
45. R. Latini, S. Masson, and I. Anand Effects of valsartan on circulating brain natriuretic peptide and norepinephrine in symptomatic chronic heart failure: the Valsartan Heart Failure Trial (Val-HeFT) Circulation 106 2002 2454 2458 (Pubitemid 35278801)
46. J. Rosenberg, F. Gustafsson, and W.J. Remme Effect of beta-blockade and ACE inhibition on B-type natriuretic peptides in stable patients with systolic heart failure Cardiovasc Drugs Ther 22 2008 305 311